UW-Milwaukee chemistry professor, students help fill gaps in state’s biohealth talent pipeline

Professor Mark Dietz (third from right) with past and present members of his research group now employed by SHINE or NorthStar: (left to right) Kevin Wolters, James Wankowski, Mohammed Abdul Momen, Michael Kaul and Cory Hawkins.
Professor Mark Dietz (third from right) with past and present members of his research group now employed by SHINE or NorthStar: (left to right) Kevin Wolters, James Wankowski, Mohammed Abdul Momen, Michael Kaul and Cory Hawkins. Credit: UW-Milwaukee

In 2012, the federal government launched efforts to establish domestic production of a medical isotope known as Molybdenum-99.  The goal was to increase access to Mo-99’s decay product, technetium-99m, a radioactive nuclear agent used in more than 40,000 medical procedures in the U.S. daily to diagnose heart disease and cancer. The agent is described by

Want to Read the Entire Article?

Become a BizTimes Insider today and get immediate access to our subscriber-only content and much more.

Become an Insider Now

Already an Insider? Log In

Sign up for BizTimes Daily Alerts

Stay up-to-date on the people, companies and issues that impact business in Milwaukee and Southeast Wisconsin

Maredithe has covered retail, restaurants, entertainment and tourism since 2018. Her duties as associate editor include copy editing, page proofing and managing work flow. Meyer earned a degree in journalism from Marquette University and still enjoys attending men’s basketball games to cheer on the Golden Eagles. Also in her free time, Meyer coaches high school field hockey and loves trying out new restaurants in Milwaukee.

No posts to display